The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which ...

Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...

Bristol Myers Squibb and Bain Capital have formed a new independent biopharmaceutical company focused on developing new ...

Bain Capital and Bristol Myers Squibb have formed a new biopharmaceutical company focused on developing new therapies for autoimmune diseases. The newly formed company launches with a $300 million ...

Thank you to Keeps for sponsoring this video! Head to to get a special offer. Want to produce documentaries like this one?

Anne Hoecker, Bain & Company's head of global technology practice, joins CNBC's 'Squawk on the Street' to discuss the growth ...

Luxury brand LVMH faced unexpected sales decline in the last quarter. Fashion and leather goods sales dropped more than anticipated. The company anticipates positive outcomes from EU-US trade ...

Three decades of experience doing consumer research and observation for corporate clients led the authors—all with Bain & Company—to identify 30 “elements of value.” ...

Parag Shah Amara Partners, the private equity fund launched by former Mahindra & Mahindra PE unit head Parag Shah, is set to raise its debut fund at ₹800 crore soon. The fund, which has roped in ...

ChrysCapital has agreed to purchase Theobroma Foods for ₹2,410 crore. The deal involves acquiring a 90% stake from promoters and ICICI Venture. Promoters will retain a 10% stake. Theobroma ...